Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Jul-22 4:38 PM View:  | Nivalis Therapeutics, Inc. (ALPN) | 15-Jul-22 | Option Exercise | 20,063 | $0.45 | $9,028.35 | < 1% 2.86M to 2.88M | |
| 27-May-22 4:18 PM View: | Elicio Therapeutics, Inc. (ELTX) | 25-May-22 | Private Purchase | 11,313 | $1.25 | $14,102.80 | < 1% 1.88M to 1.89M | |
| 25-May-22 5:58 PM View: | Elicio Therapeutics, Inc. (ELTX) | 24-May-22 | Purchase | 32,200 | $1.24 | $39,928.00 | 2% 1.69M to 1.72M | |
| 25-May-22 5:58 PM View: | Elicio Therapeutics, Inc. (ELTX) | 20-May-22 | Private Purchase | 50,000 | $1.23 | $61,500.00 | 3% 1.64M to 1.69M | |
| 29-Dec-21 4:08 PM View: | Elicio Therapeutics, Inc. (ELTX) | 28-Dec-21 | Market Purchase | 210,337 | $2.66 | $559,854.00 | 15% 1.43M to 1.64M | (3%) |
| 29-Dec-21 4:08 PM View: | Elicio Therapeutics, Inc. (ELTX) | 27-Dec-21 | Market Purchase | 66,907 | $2.55 | $170,519.00 | 5% 1.36M to 1.43M | 2% |
| 22-Dec-21 4:06 PM View: | Elicio Therapeutics, Inc. (ELTX) | 20-Dec-21 | Market Purchase | 3,527 | $2.54 | $8,975.86 | < 1% 1.36M to 1.36M | 6% |
| 20-Dec-21 6:44 PM View: | Elicio Therapeutics, Inc. (ELTX) | 17-Dec-21 | Market Purchase | 13,742 | $2.54 | $34,958.30 | 1% 1.34M to 1.36M | < 1% |
| 20-Dec-21 6:44 PM View: | Elicio Therapeutics, Inc. (ELTX) | 16-Dec-21 | Market Purchase | 27,883 | $2.55 | $70,992.90 | 2% 1.32M to 1.34M | < 1% |
| 17-Dec-21 5:13 PM View: | Elicio Therapeutics, Inc. (ELTX) | 15-Dec-21 | Market Purchase | 77,604 | $2.41 | $186,956.00 | 6% 1.24M to 1.32M | 7% |
| 21-Sep-21 10:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 17-Sep-21 | Market Sale Duplicate | 400,000 | $9.40 | $3,760,000.00 | (12%) 3.26M to 2.86M | (10%) |
| 17-Dec-21 5:13 PM View: | Elicio Therapeutics, Inc. (ELTX) | 24-Jun-21 | Payment of Exercise | 41,091 | $13.78 | $566,234.00 | (3%) 1.28M to 1.24M | 81% |
| 23-Apr-21 6:14 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 31-Mar-21 | Option Exercise | 7,650 | $3.62 | $27,718.20 | < 1% 3.25M to 3.26M | |
| 23-Apr-21 6:14 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 30-Mar-21 | Option Exercise | 7,650 | $4.09 | $31,288.50 | < 1% 3.24M to 3.25M | |
| 11-Feb-21 7:25 PM View: | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Conversion | 165,356 | $0.02 | $3,031.34 | 15% 1.07M to 1.23M | |
| 11-Feb-21 7:25 PM View: | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Payment of Exercise | 31,966 | $16.00 | $511,456.00 | (2%) 1.47M to 1.44M | |
| 11-Feb-21 7:25 PM View: | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Sale | 159,177 | $16.00 | $2,546,830.00 | (11%) 1.44M to 1.28M | |
| 11-Feb-21 7:25 PM View: | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Exercise (in-the money or at-the-money) | 237,152 | $6.43 | $1,524,890.00 | 19% 1.23M to 1.47M | |
| 22-Dec-20 5:30 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 22-Dec-20 | Acquisition (other) | 181,024 | -- | -- | 4% 4.05M to 4.23M | |
| 22-Dec-20 5:30 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 22-Dec-20 | Disposition (other) Duplicate | 993,801 | -- | -- | (23%) 4.23M to 3.24M | |
| 08-Jul-20 4:46 PM View: | Exicure, Inc. (XCUR) | 06-Jul-20 | Option Exercise | 22,240 | $0.87 | $19,369.40 | 3% 650.05K to 672.29K | |
| 06-Aug-19 5:11 PM View: | Exicure, Inc. (XCUR) | 02-Aug-19 | Purchase | 250,000 | $2.00 | $500,000.00 | 62% 400.05K to 650.05K | |
| 22-Jan-19 8:44 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-Jan-19 | Market Purchase Duplicate | 190,875 | $5.37 | $1,025,000.00 | 5% 3.86M to 4.05M | 198% |
| 28-Sep-17 9:40 PM View: | Exicure, Inc. (XCUR) | 26-Sep-17 | Grant | 52,234 | -- | -- | 100% 0 to 52.23K | |
| 28-Sep-17 9:40 PM View: | Exicure, Inc. (XCUR) | 26-Sep-17 | Acquisition (other) | 281,149 | -- | -- | 538% 52.23K to 333.38K | |
| 28-Sep-17 9:40 PM View: | Exicure, Inc. (XCUR) | 26-Sep-17 | Purchase | 66,666 | $3.00 | $199,998.00 | 20% 333.38K to 400.05K | |
| 26-Jul-17 5:10 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 24-Jul-17 | Grant | 21,739 | -- | -- | 100% 0 to 21.74K | |
| 26-Jul-17 5:10 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 24-Jul-17 | Acquisition (other) | 3,841,170 | -- | -- | 17670% 21.74K to 3.86M | |
| 25-Sep-14 4:47 PM View: | Oncothyreon Inc (CASC) | 23-Sep-14 | Grant | 250,000 | $2.00 | $500,000.00 | 6% 4.09M to 4.34M | (16%) |
| 12-Aug-14 5:12 PM View: | Oncothyreon Inc (CASC) | 08-Aug-14 | Grant | 3,776,720 | -- | -- | 7553% 50.0K to 3.83M | |
| 12-Aug-14 5:12 PM View: | Oncothyreon Inc (CASC) | 08-Aug-14 | Grant | 263,493 | -- | -- | 7% 3.83M to 4.09M | |
| 17-Oct-07 5:20 PM View: | Targanta Therapeutics Corp. (TLG) | 15-Oct-07 | Conversion | 2,092,990 | -- | -- | 100% 0 to 2.09M | |
| 17-Oct-07 5:20 PM View: | Targanta Therapeutics Corp. (TLG) | 15-Oct-07 | Purchase | 575,000 | $10.00 | $5,750,000.00 | 27% 2.09M to 2.67M |